Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer

Hua Wang; Dongxi Xiang; Ben Liu; Aina He; Helena J. Randle; Kelvin Xi Zhang; Anushka Dongre; Norman Sachs; Allison Clark; Luwei Tao; Qing Chen; Vladimir V. Botchkarev; Ying Xie; Ning Dai; Hans Clevers; Zhe Li; David M. Livingston

doi:10.1016/j.cell.2019.06.002

Related publications

Article2021

CX-5461 Sensitizes DNA Damage Repair–proficient Castrate-resistant Prostate Cancer to PARP Inhibition

Carmel Pezaro, Shahneen Sandhu, Susanne Ramm, Jennii Luu, Andrew Bakshi, David L. Goode, Elaine Sanij, Richard B. Pearson, Ross D. Hannan, Kaylene J. Simpson, Renea A. Taylor, Gail P. Risbridger, Luc Furic, Mitchell G. Lawrence, Laura H. Porter, Nicholas Choo, David Pook, Jeremy Grummet

Article2015

DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers

Tereza Vaclová, Gonzalo Goméz-López, Fernando Setién, José María García Bueno, José Antonio Macías, Alicia Barroso, Miguel Urioste, Manel Esteller, Javier Benı́tez, Ana Osório

Article2017

Relevance of DNA damage repair in the management of prostate cancer

Patricia Banks, Wen Xu, Declan G. Murphy, Paul A. James, Shahneen Sandhu

Preprint2023

Data from CX-5461 Sensitizes DNA Damage Repair–proficient Castrate-resistant Prostate Cancer to PARP Inhibition

Mitchell G. Lawrence, Laura H. Porter, Nicholas Choo, David Pook, Jeremy Grummet, Carmel Pezaro, Shahneen Sandhu, Susanne Ramm, Jennii Luu, Andrew Bakshi, David L. Goode, Elaine Sanij, Richard B. Pearson, Ross D. Hannan, Kaylene J. Simpson, Renea A. Taylor, Gail P. Risbridger, Luc Furic

Article2024

Abstract PR005: CX-5461 sensitizes DNA damage repair-proficient castrate-resistant prostate cancer to PARP inhibition

Mitchell G. Lawrence, Laura H. Porter, Nicholas Choo, Elaine Sanij, Renea A. Taylor, Richard B. Pearson, Kaylene J. Simpson, Ross D. Hannan, Shahneen Sandhu, Luc Furic